Torben Bjerregaard Larsen

  • Sdr. Skovvej 15

    9000 Aalborg

    Denmark

19992019
If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 49 Similar Profiles
Atrial Fibrillation Medicine & Life Sciences
Stroke Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Anticoagulants Medicine & Life Sciences
Warfarin Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Venous Thromboembolism Medicine & Life Sciences
Mortality Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 1999 2019

Anæmi, hæmostase og antikoagulation

Björkman, H. & Larsen, T. B., 2019, Den akutte patient. Brun Petersen, D., Callesen, T., Bjerregaard Larsen, T. & Backer Mogensen, C. (eds.). 4. ed. København: Munksgaard , p. 199-215

Research output: Contribution to book/anthology/report/conference proceedingBook chapterEducation

Development of a prediction model for recurrence risk after incident venous thromboembolism: A danish nationwide cohort study

Albertsen, I. E., Søgaard, M., Goldhaber, S. Z., Piazza, G., Overvad, T. F., Rasmussen, L. H., Larsen, T. B. & Nielsen, P. B., 2019, In : Journal of the American College of Cardiology. 73, 9, suppl. 1, p. 1940-1940 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

7 Citations (Scopus)

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

Li, G., Lip, G. Y. H., Holbrook, A., Chang, Y., Larsen, T. B., Sun, X., Tang, J., Mbuagbaw, L., Witt, D. M., Crowther, M., Thabane, L. & Levine, M. A. H., 15 Feb 2019, In : European Journal of Epidemiology. 34, 2, p. 173–190 18 p.

Research output: Contribution to journalReview articleResearchpeer-review

Anticoagulants
Atrial Fibrillation
Observational Studies
Meta-Analysis
Stroke
Atrial Fibrillation
Cohort Studies
Population
Chronic Obstructive Pulmonary Disease
Confidence Intervals
2 Citations (Scopus)
Atrial Fibrillation
Type 2 Diabetes Mellitus
Cohort Studies
Hemoglobins
Thromboembolism

Activities 2009 2015

To switch (from vitamin-K antagonist to NOAC) or not to switch – that's the question

Torben Bjerregaard Larsen (Lecturer)
25 Sep 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

NOAC: Where are we going?

Torben Bjerregaard Larsen (Lecturer)
25 Sep 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Sundhedsparlamentet - Ny folkesygdom?

Torben Bjerregaard Larsen (Participant)
12 Jun 2015

Activity: Attending an eventOrganisation or participation in workshops, courses, or seminars

The Patient Who Is Elderly, Cognitively Impaired or Falling

Torben Bjerregaard Larsen (Lecturer)
20 Jun 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Stroke Prevention and Anticoagulation

Torben Bjerregaard Larsen (Lecturer)
20 Jun 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Press / Media

Navne i noter

Torben Bjerregaard Larsen

21/12/2018

1 item of Media coverage

Press/Media: Press / Media

Aalborg får ny professor i trombose og lægemiddelovervågning

Torben Bjerregaard Larsen

07/12/2018

1 item of Media coverage

Press/Media: Press / Media

Aalborg får ny professor i trombose og lægemiddelovervågning

Torben Bjerregaard Larsen

26/11/2018

5 items of Media coverage

Press/Media: Press / Media